Back to User profile » Dr Luigino Calzetta
Papers published by Dr Luigino Calzetta:
Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside
Calzetta L, Manzetti GM, Pistocchini E, Lauro RF, Gholamalishahi S, Cazzola M, Rogliani P
Journal of Inflammation Research 2026, 19:552261
Published Date: 14 March 2026
Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary Disease
Matera MG, Calzetta L, Rogliani P, Cazzola M
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:3163-3173
Published Date: 10 September 2025
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis
Rogliani P, Manzetti GM, Cazzola M, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:1723-1736
Published Date: 27 May 2025
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene
Rogliani P, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:831-840
Published Date: 26 March 2025
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts
Cazzola M, Calzetta L, Rogliani P, Matera MG
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:2481-2495
Published Date: 21 November 2024
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review
Rogliani P, Manzetti GM, Gholamalishahi S, Cazzola M, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:2347-2360
Published Date: 29 October 2024
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
Manzetti GM, Ora J, Sepiacci A, Cazzola M, Rogliani P, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2225-2243
Published Date: 10 October 2023
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
Rogliani P, Cavalli F, Chetta A, Cazzola M, Calzetta L
Journal of Asthma and Allergy 2022, 15:565-577
Published Date: 6 May 2022
Beyond Dual Bronchodilation – Triple Therapy, When and Why
Cazzola M, Rogliani P, Laitano R, Calzetta L, Matera MG
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:165-180
Published Date: 14 January 2022
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
Rogliani P, Calzetta L
Journal of Experimental Pharmacology 2022, 14:1-5
Published Date: 11 January 2022
Detection of Small Airway Dysfunction in Asymptomatic Smokers with Preserved Spirometry: The Value of the Impulse Oscillometry System
Pisi R, Aiello M, Frizzelli A, Calzetta L, Marchi L, Bertorelli G, Pisi G, Chetta A
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2585-2590
Published Date: 14 September 2021
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review
Calzetta L, Coppola A, Ritondo BL, Matino M, Chetta A, Rogliani P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:257-279
Published Date: 12 February 2021
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
Ora J, Coppola A, Cazzola M, Calzetta L, Rogliani P
Journal of Experimental Pharmacology 2020, 12:559-574
Published Date: 8 December 2020
Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review
Rogliani P, Ritondo BL, Puxeddu E, Pane G, Cazzola M, Calzetta L
Journal of Experimental Pharmacology 2020, 12:233-253
Published Date: 6 August 2020
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
Cazzola M, Rogliani P, Calzetta L, Matera MG
Pharmacogenomics and Personalized Medicine 2020, 13:261-271
Published Date: 4 August 2020
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]
Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3597-3598
Published Date: 31 October 2018
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3115-3130
Published Date: 4 October 2018
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3469-3485
Published Date: 5 December 2017